Aimei Health (AFJK) Receives Nasdaq Delisting Notice for Late 10-K

Aimei Health Technology Co., Ltd. (AFJK) received a notice from Nasdaq on April 17, 2026, indicating non-compliance with listing rules due to the failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The report was due on March 31, 2026. While this notice has no immediate effect on the company's listing or trading, AFJK faces potential delisting if it fails to regain compliance. The company has 60 calendar days to file the report or submit a plan to Nasdaq, with a possible extension of up to 180 days from the original due date. Aimei Health is working diligently to complete and file the Annual Report and expects to regain compliance.